EXOC1 and bladder transitional cell carcinoma: Furthermore, median separation KM analyses indicated that OS was not significantly different based on EXOC1 expression in BRCA, GBM, BLCA, and AML patients (Figure 6—figure supplement 1D and Figure 6—figure supplement 1—source data 1), suggesting a role of EXOC1 in the treatment against KIRC.